Amylyx Pharmaceuticals, Inc.

Q2 2026 13F Holders

Symbol
AMLX
CUSIP
03237H101
Type
Equity
Class
COM
Num filings
223
Total reported value, excl. options
$2.15 B
Manager Report Date Value ($000) Shares Option Type